Tag: non-compliant drug manufacturers

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers

The FDA uses Import Alerts to automatically block drug shipments from non-compliant manufacturers. With the 2025 Green List initiative, enforcement against GLP-1 APIs has become the strictest in history-reshaping global supply chains and raising compliance standards.

Recent Posts

HPV-Related Cancers: Throat, Anal, and How to Prevent Them
Dec, 7 2025
HPV-Related Cancers: Throat, Anal, and How to Prevent Them

HPV causes thousands of throat and anal cancers each year in the U.S., with rising rates among men. Vaccination is the most effective way to prevent these cancers - yet coverage remains too low. Learn how HPV leads to cancer and what you can do to stop it.

Metoclopramide Outlook 2025: Emerging Research and Clinical Advances
Oct, 26 2025
Metoclopramide Outlook 2025: Emerging Research and Clinical Advances

Explore the latest research, new formulations, and future directions for metoclopramide, including safety updates, combination therapies, and personalized dosing.

Neoral (Cyclosporine) vs Alternative Immunosuppressants: Benefits, Risks & Costs
Oct, 16 2025
Neoral (Cyclosporine) vs Alternative Immunosuppressants: Benefits, Risks & Costs

A detailed side‑by‑side comparison of Neoral (Cyclosporine) with Tacrolimus, Sirolimus, Mycophenolate, and Azathioprine, covering mechanisms, dosing, side effects, cost and monitoring.

The Nocebo Effect in Medications: How Expectations Shape Side Effects
Dec, 2 2025
The Nocebo Effect in Medications: How Expectations Shape Side Effects

The nocebo effect explains why people feel side effects from medications even when the drug has no active ingredient. Expectations, not chemistry, often drive these reactions - and they're more common than you think.

Latanoprost History: From Lab Discovery to FDA Approval
Sep, 21 2025
Latanoprost History: From Lab Discovery to FDA Approval

Explore the complete journey of latanoprost-from its chemical breakthrough and clinical trials to FDA approval and its role in modern glaucoma therapy.